Richard Hausmann, Elekta CEO, named "Best MedTech CEO"
STOCKHOLM, May 20, 2020 – Elekta (EKTA-B.ST) today announced that its President and CEO, Dr. Richard Hausmann has been recognized as the "Best MedTech CEO" by MedTech Breakthrough, an independent organization that recognizes the top companies, technologies, and products in the global health and medical technology market.
Dr. Hausmann has taken bold steps to transform radiation oncology. One of these was the successful expansion of Elekta Unity, the world’s first high-field magnetic resonance-guided radiation therapy (MRgRT) system, to multiple continents around the world following its 2018 clearance in the United States and Europe. He recently celebrated the milestone of helping to fulfill more than 75 Unity orders before mid-June 2020. Under his leadership, Elekta also has advanced its position as a leader in digital health technology that is crucial to improving cancer survival.
"I’m honored to receive this award from MedTech Breakthrough,” said Richard Hausmann. “I have the privilege of working with dedicated colleagues who share my commitment to make quality radiation therapy accessible for all. Together, we have worked tirelessly to introduce paradigm-shifting technologies into the field of radiation oncology, and I believe this award is a validation of our efforts.”
Dr. Hausmann has almost three decades of experience in the medical device industry and has previously held such positions as President and CEO of GE Healthcare’s Global MR Business and as President and CEO of the Siemens Healthcare CT division.
The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work, and success across a range of health and medical technology categories. This year's program attracted thousands of nominations from across the globe.
# # #
For further information, please contact:
Mattias Thorsson, Head of Corporate Communications and Public Affairs
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager, Elekta
Tel: +1 770-670-2524, e-mail: raven.canzeri@elekta.com
Time zone: ET: Eastern Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
About MedTech Breakthrough
The MedTech Breakthrough Awards program, part of the Tech Breakthrough Awards organization, is devoted to honoring excellence in medical and health related technology companies, products and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough MedTech companies and products in categories including Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Genomics, Medical Data, Healthcare Cybersecurity and more. For more information visit www.MedTechBreakthrough.com.
